Related Experiment Video
Updated: Aug 28, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer
Xuemei Zeng1, Juan Xiao2, Xue Bai1
1Cancer Research Institute of Hengyang Medical School, University of South China; Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, Hengyang, Hunan 421001, China.
Pathology, Research and Practice
|September 18, 2022
Summary
Gastric cancer involves genetic changes and drug resistance. This review explores the circRNA/lncRNA-miRNA-mRNA axis, a key network for early diagnosis, prognosis, and potential gastric cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer is a prevalent global malignancy.
- Genetic and epigenetic factors drive carcinogenesis and chemotherapy resistance.
- Competing endogenous RNA (ceRNA) networks regulate gene expression.
Purpose of the Study:
- To review recent findings on the circRNA/lncRNA-miRNA-mRNA ceRNA network in gastric cancer.
- To highlight the potential of this network as diagnostic and prognostic markers.
- To explore therapeutic strategies targeting the ceRNA axis in gastric cancer.
Main Methods:
- Literature review of recent studies on gastric cancer ceRNA networks.
- Analysis of the roles of circRNAs, lncRNAs, and miRNAs in gastric cancer.
- Investigation of exosomal ncRNAs as biomarkers.
Main Results:
- The circRNA/lncRNA-miRNA-mRNA axis is implicated in gastric cancer's malignant behavior.
- Exosomal ncRNAs show promise as biomarkers for diagnosis, prognosis, and treatment.
- Specific ceRNA networks offer insights into gastric cancer progression.
Conclusions:
- The ceRNA regulatory network is crucial in gastric carcinogenesis and drug resistance.
- The circRNA/lncRNA-miRNA-mRNA axis presents potential for early diagnosis and therapy.
- Exosomal ncRNAs are valuable biomarkers for gastric cancer management.
Related Concept Videos
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
lncRNA - Long Non-coding RNAs
8.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Nucleolus
9.0K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.0K

